Navigation Links
Asia-Pacific Asthma Market Hit $3.5 Billion in 2014 and Will Reach $5.6 Billion by 2021, Says GBI Research
Date:3/8/2016

LONDON, March 8, 2016 /PRNewswire/ --

A new report from business intelligence provider GBI Research - Asthma Therapeutics in Asia-Pacific Markets to 2021 - states that the asthma therapeutics market in the Asia-Pacific (APAC) region will grow from $3.5 billion in 2014 to $5.6 billion by 2021, at a strong Compound Annual Growth Rate (CAGR) of 7.2%.

The primary driver of this considerable rise is the prevalence of asthma across the APAC countries, which include China, India, Australia, South Korea, and Japan. The condition is burgeoning due to aging populations and increases in air pollution, dust and pollen levels, which both cause and exacerbate asthma in children.

Analyst Aswini Nath says: "As well as the increasing incidence of the disease, six costly biologics are set to enter the APAC asthma market which will push its value up considerably. These consist of GlaxoSmithKline's, mepolizumab, Teva's reslizumab, Chugai/Roche's lebrikizumab, Sanofi/Regeneron's dupilumab, and AstraZeneca's tralokinumab and benralizumab.

"The most advanced of these drugs is mepolizumab, which is currently at the Pre-registration stage in Japan, while the other five monoclonal antibodies (mAbs) are in Phase III development in the APAC region. As the cost of these treatments is likely to be high in comparison with more established drugs, strong uptake could well increase the cost of treatment for asthma patients."

GBI Research also states that India has the highest number of asthma sufferers of the five APAC countries. In 2014, 53.6 million people were estimated to be living with the disease, which is approximately 52.4% of the total assessed Asia-Pacific prevalence.

Nath elaborates: "Lack of knowledge of the disease condition among the public, an increasing aging population, and increasing air and dust pollution will mean the prevalence rate will continue to rise over the period, resulting in 57 million sufferers by 2021.

"Despite this, India only represented 12.2% of the APAC asthma market in 2014, which reflects the low cost of therapy in comparison with the other assessed countries."

Japan, by contrast, was the largest market of the five APAC countries in 2014 at $1.8 billion, and will continue its lead to 2021, growing to $3 billion at a CAGR of 7.1%.

"As Japan is ranked only third of the five countries in terms of disease prevalence, this reflects the relatively high cost of drugs, and the country's readiness to adopt promising new molecules such as the IL-targeting mAbs," the analyst concludes.

Sample pages of GBI Research's report Asthma Therapeutics in Asia-Pacific Markets to 2021 are available upon request

About GBI Research

GBI Research is a leading provider of business intelligence reports, offering actionable data and forecasts based on the insights of key healthcare industry influencers to ensure you stay up-to-date with the latest market trends. Connect with GBI Research on social media for the latest healthcare market updates: Facebook | LinkedIn | Twitter

For more information about our offerings, please contact us on:

+44(0)161-359-5817

 


'/>"/>
SOURCE GBI Research
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Worth $825 Million by 2017
2. Development of New Technologies Spurs Molecular Diagnostic Test Volumes in Asia-Pacific, Finds Frost & Sullivan
3. UBM Canon and MD+DI, the Global MedTech Authority, Publishes New Infographic Reviewing the Asia-Pacific MedTech Market
4. Frost & Sullivan: SMBG Suppliers Look to Tap the Huge Underpenetrated Diabetic Population in Asia-Pacific
5. The Global Healthcare IT Market Report - North America Commands Highest Market Share However Asia-Pacific Set to Have the Highest CAGR
6. Increasing Demand from End-user Applications Boosts Asia-Pacific Antimicrobial Coatings Market, Finds Frost & Sullivan
7. Frost & Sullivan: Demand for Faster Healing Spurs Sale of Advanced Wound Care and Modern Wound Closure Devices in Asia-Pacific
8. GenSpera Presents G-202 HCC Clinical Trial Update at 5th Asia-Pacific Primary Liver Cancer Expert Meeting
9. Asia-Pacific Cardiovascular Prosthetic Devices Market Outlook to 2020
10. Asia-Pacific Interventional Cardiology Market Outlook to 2020
11. Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
Breaking Medicine News(10 mins):